StockData
Geron Corp logo

Geron Corp (GERN) stock

GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$1.00+0.06 (+6.17%)

Close on Nov 17, 2026Market cap $642.47MP/E –Yield –

Geron EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Geron's EV/EBITDA was 746.4× on Oct 31, 2016.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2016Oct 31, 2016746.4×–

More Geron figures

See a number that looks wrong?